Company Profile - MYOS RENS Technology Inc

Introduction

MedAvail Holdings Inc (MedAvail Holdings), formerly MYOS RENS Technology Inc, is a bionutrition and biotherapeutics company that discovers, develops and commercializes products that improve muscle health and function. The company offers fortetropin, a unique bioactive composition derived from fertilized chicken egg yolk that is processed using a patented technology which preserves its biological integrity and bioactivity for increase of muscle size and lean body mass in conjunction with resistance training. MYOS RENS’s biotherapeutics research and development activities are concentrated on medical health, consumer health, nutrition and animal health. It also undertakes human clinical trials and pre-clinical studies for the treatment of various diseases such as sarcopenia, cachexia and degenerative muscle disease. The company partners with other institutions for its research and development activities. MedAvail Holdings is headquartered in Ontario, Canada.